Azilsartan Impurity 35 | CAS 161862-32-4 - Request Quote
Azilsartan Impurity 35
| SZ CAT No: | SZ-A004060 |
| CAS No | 161862-32-4 |
| Mol.F. | C15H11BrN2O2 |
| Mol.Wt. | 331.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Azilsartan Impurity 35 is chemically 3-(4'-(Bromomethyl)-[1,1'-biphenyl]-2-yl)-1,2,4-oxadiazol-5(4H)-one. Azilsartan Impurity 35 is supplied with detailed characterization data compliant with regulatory guideline. Azilsartan Impurity 35 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Azilsartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 161862-32-4
Purchase 161862-32-4
Order 161862-32-4
Enquire 161862-32-4
price of 161862-32-4
161862-32-4 Supplier
161862-32-4 Manufacturer
161862-32-4 Exporter
buy high quality Azilsartan Impurity 35
Purchase Azilsartan Impurity 35
Azilsartan Impurity 35 suppliers
Azilsartan Impurity 35 manufacturers
Azilsartan Impurity 35 price
Order Azilsartan Impurity 35
Enquire Azilsartan Impurity 35
Azilsartan Impurity 35 cost
Azilsartan Impurity 35 Supplier
Azilsartan Impurity 35 Distributor
Azilsartan Impurity 35 for Method Validation
Azilsartan Reference Standard
Azilsartan Impurity 35 for ANDA Filing
Azilsartan Impurity 35 for Forced Degradation Studies
Azilsartan Impurity 35 Identification Standards
Azilsartan Impurity 35 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.